Santosh Kumar Mahil joins Shilpa Pharma Life Sciences as CEO
Karnataka: Shilpa Medicare Limited has announced the appointment of Santosh Kumar Mahil, as Chief Executive Officer (CEO) of Shilpa Pharma Life Sciences Limited, a wholly-owned subsidiary of the Company.
Santosh Kumar Mahil, aged 51, boasts over 28 years of experience in the pharmaceutical sector. He holds an M.Sc. in Chemistry from H.P. University Shimla. His extensive experience spans API, Formulation, and Intermediate sectors on a global scale, showcasing his adeptness in making critical decisions and navigating complex business challenges while ensuring consensus among diverse functional groups. Prior to this role, Mr. Santosh Kumar Mahil served as the Chief Commercial and Business Officer at Unichem Laboratories Limited, where he provided strategic leadership and spearheaded various initiatives for organizational advancement. He has also held significant positions at companies such as USV Limited, RLFC, Lupin, and Sun Pharmaceuticals.
Shilpa Medicare Limited started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of API and Formulation globally in different regulated markets.
Read also: Shilpa Medicare secures Europe approval for smoking cessation drug Varenicline
Next Story
